PRESS RELEASEAB SCIENCE PATENT FOR MASITINIB IN THE TREATMENT OF SICKLE CELL DISEASE FORMALLY GRANTED IN THE UNITED STATES WITH A PROTECTION ...

Knowable Magazine reports 2025 faced turmoil in U.S. science amid job cuts and budget slashes, yet saw advances in gene ...

We are now working to make pimicotinib available to patients in China as quickly as possible, as we continue to progress applications with regulatory authorities in additional markets.” TGCT is a rare ...

A San Diego startup may have created what the scientific community has talked about for decades – a kind of universal flu ...

Two bright students from Berhampur's private schools have triumphed at the National Urja Mela in New Delhi. Chinmayee ...

Arcellx (ACLX) is positioned to disrupt multiple myeloma cell therapy with anito-cel, leveraging superior efficacy, safety, and scalable manufacturing.

Happy New Year 2026! The Rancho Santa Fe Library offers unique activities, and opportunities to for you to try new things and read fascinating books. Acrylic Painting Class with Carol Murphy ...

The Trump administration has adopted policies condemning a sizable group of its core MAGA supporters — miners, firemen, ...

Gage survived, but unfortunately, it wasn't a total happy ending. His friends and doctor said that, post-accident, he was “no ...

Phase 1 data confirms SAB-142 does not cause serum sickness and has low/no immunogenicity at any dose and in all cohorts, including redosed ...

Policy, precision medicine, and new ways of delivering therapeutics were popular topics in 2025 among readers of ...